{
    "construct_crystal": {
        "pdb": "3DQB",
        "ligand_id_type": "Other",
        "ligand_activity": "agonist",
        "ligand_id": "-",
        "pdb_name": "3dqb_partial",
        "ligand_name": "Gta peptide",
        "uniprot": "opsd_bovin"
    },
    "unparsed": {
        "mod_remark_6": "S-palmitoyl-L-cysteine",
        "other_lig_id": "-",
        "aamod_pair_two_3": "401",
        "aamod_pair_two_5": "323",
        "mod_remark_2": "N4-(N-acetylamino)glucosyl-L-asparagine",
        "mod_remark_3": "N4-(N-acetylamino)glucosyl-L-asparagine",
        "aamod_pair_one_6": "702",
        "aamod_pair_one_5": "701",
        "aamod_pair_one_2": "2",
        "aamod_pair_two_6": "322",
        "aamod_pair_one_3": "15",
        "aamod_pair_two_2": "501",
        "mod_remark_5": "S-palmitoyl-L-cysteine"
    },
    "auxiliary": {},
    "expression": {
        "expr_other": "-",
        "other_host": "-",
        "expr_remark": "\r\n",
        "expr_method": "Other [In case of E.Coli or Yeast recombinant expression]",
        "host_cell": "other [See next field]",
        "other_host_cell": "-",
        "host_cell_type": "other [See next field]"
    },
    "mutations": [],
    "modifications": [
        {
            "type": "Disulfide bond",
            "position": [
                "pair",
                [
                    "110",
                    "187"
                ]
            ],
            "remark": "L-cystine"
        }
    ],
    "raw_data": {
        "deterg_concentr": "1",
        "other_lig_id": "-",
        "undefined_3": "",
        "deterg_concentr_unit": "%w/v",
        "lipid_concentr": "",
        "wt_aa": "",
        "aamod_single_4": "",
        "protein_conc_unit": "-",
        "expr_method": "Other [In case of E.Coli or Yeast recombinant expression]",
        "undefined_4": "",
        "aamod_end_6": "",
        "url": "gpcrdb.org",
        "signal": "",
        "aamod_end": "",
        "aamod_position_6": "pair",
        "aamod_pair_one_3": "15",
        "time_expr": "",
        "aamod_single": "",
        "aamod_position": "",
        "concentr_2": "3.2",
        "protein_type": "",
        "ph": "single_ph",
        "aamod_pair_two_5": "323",
        "deterg_type": "other [See next field]",
        "aamod_start": "",
        "deletion_single": "",
        "aamod_single_2": "",
        "ligand_conc": "",
        "aamod_pair_two_2": "501",
        "aamod_start_4": "",
        "undefined_2": "",
        "aamod_end_2": "",
        "pi_name": "gpcrdb",
        "host_cell": "other [See next field]",
        "other_prot_cleavage": "",
        "aamod_end_3": "",
        "aamod_start_2": "",
        "presence": "",
        "prot_cleavage": "",
        "other_deterg": "1% b-D-octylglucopyranoside",
        "aamod": "",
        "aamod_position_5": "pair",
        "lipid": "",
        "concentr_unit_2": "mM",
        "ligand_name": "Gta peptide",
        "aamod_start_6": "",
        "other_tag": "",
        "insert_pos_single": "",
        "undefined_5": "",
        "other_deterg_type": "b-D-octylglucopyranoside",
        "aamod_pair_two_4": "187",
        "ph_range_one": "",
        "aamod_start_3": "",
        "name_cont": "gpcrdb",
        "ins_start": "",
        "ligand_conc_unit": "",
        "aa_no": "",
        "delet_end": "",
        "protein_concentr": "-",
        "pdb": "3DQB",
        "mod_remark_2": "N4-(N-acetylamino)glucosyl-L-asparagine",
        "detergent": "other [See next field]",
        "lcp_add": "",
        "other_lcp_lipid": "",
        "aamod_end_4": "",
        "aamod_pair_one_2": "2",
        "aamod_pair_one_4": "110",
        "additive_concentr": "-",
        "linker_seq": "",
        "lcp_conc": "",
        "ph_range_two": "",
        "fusion_prot": "",
        "presence_expr": "",
        "lipid_concentr_unit": "",
        "mut_type": "",
        "aamod_start_5": "",
        "undefined_6": "",
        "ligand_id_type": "Other",
        "crystal_method": "vapour diffusion",
        "mut_aa": "",
        "csrfmiddlewaretoken": "cfQ6NguPigFPAJtN8RekzQEzdsHGpuLMT7lRctQr5uyUZ5rzbeX3hc5YPyxxKPyE",
        "aamod_4": "Disulfide bond",
        "other_signal": "",
        "aamod_pair_one_5": "701",
        "aamod_single_5": "",
        "aamod_single_6": "",
        "crystal_remark": "Alternatively, GalphaCT was mixed with solubilized opsin in a 4:1 molar ratio for crystallization. Crystallization screens by the sparse matrix crystallization method were carried out using the hanging-drop vapour diffusion method and more than 2,000 crystallization conditions. Promising conditions were systematically screened further by altering protein concentration, precipitation agents and pH",
        "aamod_pair_two": "",
        "insert_pos_type": "",
        "deletion": "",
        "concentr_3": "0.1",
        "chemical_comp": "",
        "concentr": "",
        "other_lig_act": "",
        "address": "\t\t\t\t\t\t\t",
        "mut_remark": "",
        "concentr_unit_3": "M",
        "tag": "",
        "concentr_unit": "",
        "aamod_position_4": "pair",
        "aamod_pair_two_6": "322",
        "pdb_name": "3dqb_partial",
        "deterg_conc": "1",
        "ph_single": "6.0",
        "other_lipid": "",
        "ligand_activity": "agonist",
        "crystal_type": "other [See next field]",
        "delet_start": "",
        "aamod_pair_one": "",
        "expr_remark": "\r\n",
        "aamod_end_5": "",
        "addit_concentr_unit": "-",
        "lcp_conc_unit": "",
        "other_host_cell": "-",
        "aamod_pair_one_6": "702",
        "other_crystal_type": "hanging drops",
        "mod_remark_5": "S-palmitoyl-L-cysteine",
        "other_host": "-",
        "other_method": "",
        "aamod_pair_two_3": "401",
        "date": "11/18/2016",
        "pi_email": "info@gpcrdb.org",
        "mod_remark_6": "S-palmitoyl-L-cysteine",
        "aamod_single_3": "",
        "ins_end": "",
        "temperature": "277K",
        "aamod_position_2": "pair",
        "expr_other": "-",
        "uniprot": "opsd_bovin",
        "deterg_conc_unit": "% ",
        "host_cell_type": "other [See next field]",
        "chemical_comp_2": "Ammonium sulfate",
        "position": "",
        "sol_remark": "",
        "mod_remark_3": "N4-(N-acetylamino)glucosyl-L-asparagine",
        "chem_enz_treatment": "None",
        "aamod_position_3": "pair",
        "mod_remark_4": "L-cystine",
        "chemical_comp_3": "MES or Sodium Citrate buffer",
        "ligand_id": "-",
        "mod_remark": "",
        "lcp_lipid": "Please Select",
        "solub_additive": "-"
    },
    "solubilization": {
        "chem_enz_treatment": "None",
        "deterg_concentr": "1",
        "deterg_type": "other [See next field]",
        "solub_additive": "-",
        "deterg_concentr_unit": "%w/v",
        "addit_concentr_unit": "-",
        "additive_concentr": "-"
    },
    "error": 0,
    "contact_info": {
        "name_cont": "gpcrdb",
        "pi_name": "gpcrdb",
        "url": "gpcrdb.org",
        "date": "11/18/2016",
        "address": "\t\t\t\t\t\t\t",
        "pi_email": "info@gpcrdb.org"
    },
    "error_msg": [],
    "crystallization": {
        "crystal_type": "other [See next field]",
        "deterg_concentr_unit": "%w/v",
        "deterg_concentr": "1",
        "temperature": "277K",
        "ph": "single_ph",
        "deterg_conc_unit": "% ",
        "chemical_components": [
            {
                "component": "Ammonium sulfate",
                "value": "3.2",
                "unit": "mM"
            },
            {
                "component": "MES or Sodium Citrate buffer",
                "value": "0.1",
                "unit": "M"
            }
        ],
        "other_deterg": "1% b-D-octylglucopyranoside",
        "crystal_method": "vapour diffusion",
        "protein_concentr": "-",
        "protein_conc_unit": "-",
        "other_crystal_type": "hanging drops",
        "detergent": "other [See next field]",
        "other_deterg_type": "b-D-octylglucopyranoside",
        "ph_single": "6.0",
        "deterg_conc": "1",
        "crystal_remark": "Alternatively, GalphaCT was mixed with solubilized opsin in a 4:1 molar ratio for crystallization. Crystallization screens by the sparse matrix crystallization method were carried out using the hanging-drop vapour diffusion method and more than 2,000 crystallization conditions. Promising conditions were systematically screened further by altering protein concentration, precipitation agents and pH"
    },
    "deletions": []
}